{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:36:51Z","timestamp":1791549411864,"version":"4.3.4"},"reference-count":329,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejmech.2021.113193","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T20:13:54Z","timestamp":1611000834000},"page":"113193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5295-4880","authenticated-orcid":false,"given":"Om P.S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Beteck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2440-4993","authenticated-orcid":false,"given":"Lesetja J.","family":"Legoabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113193_bib1","first-page":"39","article-title":"Recent advances in antimalarial drug discovery\u2014challenges and opportunities","author":"Sharma","year":"2015","journal-title":"An Overview of Tropical Diseases"},{"key":"10.1016\/j.ejmech.2021.113193_bib2","doi-asserted-by":"crossref","first-page":"111353","DOI":"10.1016\/j.ejmech.2019.05.043","article-title":"New dimensions in the field of antimalarial research against malaria resurgence","volume":"181","author":"Narula","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1475-2875-10-378","article-title":"A\u00a0new world malaria map: Plasmodium falciparum endemicity in 2010","volume":"10","author":"Gething","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12936-016-1524-y","article-title":"Plasmodium vivax msp-3\u03b1 polymorphisms: analysis in the Indian subcontinent","volume":"15","author":"Verma","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pt.2008.01.007","article-title":"Plasmodium vivax in India","volume":"24","author":"Joshi","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113193_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1475-2875-12-243","article-title":"Molecular epidemiology of Plasmodium vivax in Latin America: polymorphism and evolutionary relationships of the circumsporozoite gene","volume":"12","author":"Gonz\u00e1lez-Cer\u00f3n","year":"2013","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113193_bib7","volume":"2019","year":"2019","journal-title":"World malaria report"},{"key":"10.1016\/j.ejmech.2021.113193_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/CMR.15.2.278-293.2002","article-title":"Integrated approach to malaria control","volume":"15","author":"Shiff","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113193_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.ento.50.071803.130439","article-title":"Mosquito behavior and vector control","volume":"50","author":"Pates","year":"2005","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.ejmech.2021.113193_bib10","article-title":"C.G.o.V. Control, A research agenda for malaria eradication: vector control,","volume":"8","author":"m","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/HPD.S16590","article-title":"Malaria: control, elimination, and eradication","volume":"8","author":"Ojurongbe","year":"2016","journal-title":"Hum. Parasit. Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib12","first-page":"112215","author":"Qin","year":"2020","journal-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review, Eur. J. Med. Chem"},{"key":"10.1016\/j.ejmech.2021.113193_bib13","first-page":"112955","article-title":"An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins","author":"Madhav","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib15","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","article-title":"Spread and evolution of Plasmodium falciparum drug resistance","volume":"58","author":"Mita","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2021.113193_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.05.009","article-title":"Drug targets for resistant malaria: historic to future perspectives","volume":"104","author":"Kumar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113193_bib18","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1111\/j.1742-4658.2007.05999.x","article-title":"Drug-resistant malaria\u2212 an insight","volume":"274","author":"Hyde","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2021.113193_bib19","article-title":"Artemisinin-based peroxide compounds as broad spectrum anti-infective agents, in","author":"Avery","year":"2005","journal-title":"Google Patents"},{"key":"10.1016\/j.ejmech.2021.113193_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1039\/C4NP00113C","article-title":"Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin","volume":"32","author":"Corsello","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2021.113193_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11427-015-4948-7","article-title":"The discovery of artemisinin and the Nobel prize in Physiology or medicine, sci. China:","volume":"58","author":"Su","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2021.113193_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113193_bib23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1590\/0001-3765201820170830","article-title":"Current antimalarial therapies and advances in the development of semi-synthetic artemisinin derivatives","volume":"90","author":"Pinheiro","year":"2018","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ejmech.2021.113193_bib24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1039\/C5NP00133A","article-title":"Artemisinin, a miracle of traditional Chinese medicine","volume":"32","author":"Kong","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2021.113193_bib25","doi-asserted-by":"crossref","first-page":"112044","DOI":"10.1016\/j.ejmech.2020.112044","article-title":"Artemisinin-derived hybrids and their anticancer activity","volume":"188","author":"Gao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/acsomega.9b02600","article-title":"Synthesis and evaluation of artemisinin-based hybrid and dimer derivatives as Antimelanoma agents","volume":"5","author":"Botta","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2021.113193_bib27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.0c00131","article-title":"Artemisinin derivatives with Antimelanoma activity show inhibitory effect against human DNA Topoisomerase 1","volume":"11","author":"Botta","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558894","article-title":"L.H. du Plessis, anti-Melanoma activities of artemisone and prenylated amino-artemisinins in combination with known anticancer drugs","volume":"11","author":"Wong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113193_bib29","doi-asserted-by":"crossref","first-page":"107706","DOI":"10.1016\/j.pharmthera.2020.107706","article-title":"Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing","author":"Augustin","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113193_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.529881","article-title":"Artemisinins as anticancer drugs: novel therapeutic approaches, molecular mechanisms, and clinical trials","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113193_bib31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2021.113193_bib32","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2021.113193_bib33","first-page":"804","article-title":"The antiviral activities of artemisinin and artesunate, Clin. Infect","volume":"47","author":"Efferth","year":"2008","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib34","doi-asserted-by":"crossref","first-page":"107696","DOI":"10.1016\/j.pharmthera.2020.107696","article-title":"The potential of artemisinins as anti-obesity agents via modulating the immune system","author":"Shen","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113193_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.568864","article-title":"Antidiabetic effect of artemether in Db\/Db mice involves regulation of AMPK and PI3K\/Akt pathways","volume":"11","author":"Bai","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2021.113193_bib36","doi-asserted-by":"crossref","first-page":"8639523","DOI":"10.1155\/2018\/8639523","article-title":"Antidiabetic and antiobesity effects of artemether in db\/db mice","volume":"2018","author":"Guo","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2021.113193_bib37","doi-asserted-by":"crossref","first-page":"127581","DOI":"10.1016\/j.bmcl.2020.127581","article-title":"In\u00a0vitro efficacy of synthesized artemisinin derivatives against Leishmania promastigotes","volume":"30","author":"Aucamp","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2010.03.008","article-title":"Efficacy of artemisinin in experimental visceral leishmaniasis","volume":"36","author":"Sen","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2021.113193_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/435713","article-title":"Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives","volume":"2015","author":"Shi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2021.113193_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.micpath.2018.03.014","article-title":"Antibacterial mechanism of artemisinin\/beta-cyclodextrins against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"118","author":"Lin","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2021.113193_bib41","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1128\/AAC.00407-12","article-title":"Anti-Helicobacter pylori potential of artemisinin and its derivatives","volume":"56","author":"Goswami","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tube.2019.03.004","article-title":"Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin","volume":"115","author":"Patel","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2021.113193_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm6030030","article-title":"Novel pharmacological activity of artesunate and artemisinin: their potential as anti-tubercular agents","volume":"6","author":"Choi","year":"2017","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib44","article-title":"Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics","author":"Dolivo","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2021.113193_bib45","article-title":"The therapeutic effect of artemisinin and its derivatives in kidney disease, front","volume":"11","author":"Xia","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2021.113193_bib46","doi-asserted-by":"crossref","first-page":"104901","DOI":"10.1016\/j.phrs.2020.104901","article-title":"Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","author":"Cheong","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113193_bib47","first-page":"2524","article-title":"Anti-SARS-CoV-2 potential of artemisinins in\u00a0vitro, ACS Infect","volume":"6","author":"Cao","year":"2020","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijid.2020.08.032","article-title":"Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: in\u00a0vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate","volume":"99","author":"Gendrot","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42269-020-00429-2","article-title":"Antagonistic effects of some commonly used herbs on the efficacy of Artemisinin derivatives in the treatment of malaria in experimental mice","volume":"44","author":"Idowu","year":"2020","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.ejmech.2021.113193_bib50","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/ja00341a054","article-title":"Total synthesis of qinghaosu","volume":"105","author":"Schmid","year":"1983","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113193_bib51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0040-4020(01)87487-1","article-title":"Total synthesis of arteannuin and deoxyarteannuin","volume":"42","author":"Xing-Xiang","year":"1986","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib52","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1016\/S0040-4039(00)96582-1","article-title":"The total synthesis of (+)-artemisinin and (+)-9-desmethyltemesinin","volume":"28","author":"Avery","year":"1987","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib53","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0040-4039(00)94621-5","article-title":"Stereoselective synthesis of artemisinin","volume":"31","author":"Ravindranathan","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib54","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1021\/ja00029a028","article-title":"Stereoselective total synthesis of (+)-artemisinin, the antimalarial constituent of Artemisia annua L","volume":"114","author":"Avery","year":"1992","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113193_bib55","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/0040-4039(93)88052-K","article-title":"A\u00a0total synthesis of the antimarial natural product (+)-qinghaosu","volume":"34","author":"Hsing-Jang","year":"1993","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib56","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1016\/S0040-4039(00)73532-5","article-title":"New synthetic strategies towards (+)-artemisinin","volume":"35","author":"Bhonsle","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib57","first-page":"321","article-title":"A\u00a0novel asymmetric total synthesis of (+)-artemisinin, Synth","volume":"26","author":"Constantino","year":"1996","journal-title":"Commun. Now."},{"key":"10.1016\/j.ejmech.2021.113193_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0040-4039(02)02500-5","article-title":"Stereoselective total synthesis of (+)-artemisinin","volume":"44","author":"Yadav","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib59","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.tet.2010.01.051","article-title":"A\u00a0concise stereoselective total synthesis of (+)-artemisinin","volume":"66","author":"Yadav","year":"2010","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib60","doi-asserted-by":"crossref","first-page":"13577","DOI":"10.1021\/ja3061479","article-title":"A\u00a0concise synthesis of (+)-artemisinin,","volume":"134","author":"Zhu","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113193_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cej.2016.02.085","article-title":"Optimisation of the photochemical oxidation step in the industrial synthesis of artemisinin","volume":"294","author":"Burgard","year":"2016","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/op4003196","article-title":"Semisynthetic artemisinin, the chemical path to industrial production","volume":"18","author":"Turconi","year":"2014","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2021.113193_bib63","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nature04640","article-title":"Production of the antimalarial drug precursor artemisinic acid in engineered yeast","volume":"440","author":"Ro","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113193_bib64","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/anie.201107446","article-title":"Continuous-flow synthesis of the anti-malaria drug artemisinin","volume":"51","author":"L\u00e9vesque","year":"2012","journal-title":"Angew. Chem., Int"},{"key":"10.1016\/j.ejmech.2021.113193_bib65","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1002\/chem.201204558","article-title":"A\u00a0continuous-flow process for the synthesis of artemisinin","volume":"19","author":"Kopetzki","year":"2013","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2021.113193_bib66","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1002\/anie.201801424","article-title":"Literally green chemical synthesis of artemisinin from plant extracts","volume":"57","author":"Triemer","year":"2018","journal-title":"Angew. Chem., Int"},{"key":"10.1016\/j.ejmech.2021.113193_bib67","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1021\/acscatal.8b04960","article-title":"Porphyrinic metal\u2013organic frameworks installed with Br\u00f8nsted acid sites for efficient tandem semisynthesis of artemisinin","volume":"9","author":"Feng","year":"2019","journal-title":"ACS Catal."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113193_bib68","first-page":"3575","article-title":"4-trioxane-based structural scaffold, drug des., Dev. Ther., 10","volume":"1","author":"Rudrapal","year":"2016","journal-title":"Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to"},{"key":"10.1016\/j.ejmech.2021.113193_bib69","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0020-7519(02)00194-7","article-title":"Artemisinin: mechanisms of action, resistance and toxicity","volume":"32","author":"Meshnick","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113193_bib70","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)60952-7","article-title":"Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism (s) of action","author":"Cumming","year":"1996"},{"key":"10.1016\/j.ejmech.2021.113193_bib71","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1016\/j.bmcl.2009.07.013","article-title":"Spiroadamantyl 1, 2, 4-trioxolane, 1, 2, 4-trioxane, and 1, 2, 4-trioxepane pairs: relationship between peroxide bond iron (II) reactivity, heme alkylation efficiency, and antimalarial activity","volume":"19","author":"Wang","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib72","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A\u00a0medicinal chemistry perspective on artemisinin and related endoperoxides,","volume":"47","author":"O\u2019Neill","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib73","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin\u2014the debate continues","volume":"15","author":"O\u2019neill","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113193_bib74","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/0006-2952(92)90713-S","article-title":"Hemin-catalyzed decomposition of artemisinin (qinghaosu)","volume":"43","author":"Zhang","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113193_bib75","first-page":"7","article-title":"Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in\u00a0vitro, Am","volume":"56","author":"Kamchonwongpaisan","year":"1997","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib76","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/np50086a018","article-title":"Stereoselective synthesis and antimalarial activity of \u03b1-artelinic acid from artemisinin","volume":"55","author":"Vishwakarma","year":"1992","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113193_bib77","first-page":"519","article-title":"Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice, Am","volume":"59","author":"Nontprasert","year":"1998","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1039\/c2md00277a","article-title":"Antimalarial peroxides: advances in drug discovery and design","volume":"3","author":"Slack","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113193_bib79","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/AAC.00510-08","article-title":"Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate","volume":"52","author":"de Pilla Varotti","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib80","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113193_bib81","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113193_bib82","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(20)30560-2","article-title":"Are three drugs for malaria better than two?","volume":"395","author":"Rosenthal","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113193_bib83","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113193_bib84","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12936-019-2955-z","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance","volume":"18","author":"White","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib85","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/jm00394a037","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives","volume":"30","author":"Lin","year":"1987","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib86","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1021\/jm00126a017","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain","volume":"32","author":"Lin","year":"1989","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib87","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/jm9607919","article-title":"Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-Substituted phenyl)-4(R or S)-[10(\u03b1 or \u03b2)-dihydroartemisininoxy]butyric Acids 1-6","volume":"40","author":"Lin","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib88","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/jm9604944","article-title":"Mechanism-based design of parasite-targeted artemisinin Derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin","volume":"39","author":"O\u2019Neill","year":"1996","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1021\/jm000987f","article-title":"Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in\u00a0vivo metabolism of novel, potent C-10-Phenoxy derivatives of dihydroartemisinin","volume":"44","author":"O\u2019Neill","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib90","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0968-0896(03)00499-1","article-title":"Artemisinin derivatives bearing Mannich base group: synthesis and antimalarial activity","volume":"11","author":"Li","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib91","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1021\/jm060826x","article-title":"New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice","volume":"49","author":"Singh","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib92","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.bmcl.2007.12.074","article-title":"Orally active esters of dihydroartemisinin: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice","volume":"18","author":"Singh","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib93","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.bmcl.2016.02.019","article-title":"New orally active diphenylmethyl-based ester analogues of dihydroartemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice","volume":"26","author":"Chaudhary","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib94","doi-asserted-by":"crossref","first-page":"47959","DOI":"10.1039\/C5RA07697H","article-title":"In\u00a0vitro antimalarial activity and molecular modeling studies of novel artemisinin derivatives","volume":"5","author":"Gaur","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113193_bib95","unstructured":"U. Ajima, J.O. Onah, N.N. Wannang, I. Gurumtet, Synthesis and antimalarial evaluation of a dihydroartemisinin-Histone Deacetylase inhibitor conjugate, Pharm. Chem. J., 7 30\u201342.."},{"key":"10.1016\/j.ejmech.2021.113193_bib96","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/jm00087a021","article-title":"Antimalarial activity of new dihydroartemisinin derivatives. 5. Sugar analogs","volume":"35","author":"Lin","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib97","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S0031182019001306","article-title":"In\u00a0vivo antimalarial activity and pharmacokinetics of artelinic acid-choline derivative liposomes in rodents","volume":"147","author":"Duan","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2021.113193_bib98","first-page":"1532","article-title":"A\u00a0chemically stable fluorescent mimic of dihydroartemisinin, artemether, and arteether with conserved bioactivity and specificity shows high pharmacological relevance to the antimalarial drugs, ACS infect","volume":"6","author":"Sissoko","year":"2020","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib99","first-page":"2080","article-title":"Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7","volume":"vol. 113","author":"Ismail","year":"2016"},{"key":"10.1016\/j.ejmech.2021.113193_bib100","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1021\/jm00167a036","article-title":"Synthesis and antimalarial activity of (+)-deoxoartemisinin","volume":"33","author":"Jung","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1055\/s-1990-21234","article-title":"A\u00a0concise and stereoselective synthesis of (+)-12-n-butyldeoxoartemisinin","volume":"1990","author":"Jung","year":"1990","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2021.113193_bib102","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/jm00004a007","article-title":"Synthesis and antimalarial activities of 12. beta.-Allyldeoxoartemisinin and its derivatives","volume":"38","author":"Pu","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib103","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/jm000195l","article-title":"Syntheses and antimalarial activities of 10-substituted deoxoartemisinins","volume":"43","author":"Ma","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib104","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0960-894X(01)81060-X","article-title":"A\u00a0concise synthesis of 12-(3\u2019-hydroxy-n-propyl)-deoxoartemisinin, Bioorg","volume":"1","author":"Jung","year":"1991","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/jm980529v","article-title":"Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family","volume":"42","author":"Posner","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib106","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0960-894X(98)00160-7","article-title":"Stability of acetal and non acetal-type analogs of artemisinin in simulated stomach acid","volume":"8","author":"Jung","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib107","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/S0040-4020(98)01170-3","article-title":"Antimalarial artemisinin analogs. Synthesis via chemoselective C-C bond formation and preliminary biological evaluation","volume":"55","author":"O\u2019Dowd","year":"1999","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib108","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1021\/jm9903545","article-title":"Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1, 2, 4-trioxane artemether","volume":"42","author":"O\u2019Neill","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib109","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/jm0109816","article-title":"Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues","volume":"45","author":"Hindley","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib110","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1021\/jm020244p","article-title":"Synthesis, stability, and antimalarial activity of new hydrolytically stable and water-soluble (+)-deoxoartelinic acid","volume":"45","author":"Jung","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib111","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/ol017227z","article-title":"First synthesis of 10\u03b1-(trifluoromethyl) deoxoartemisinin","volume":"4","author":"Chorki","year":"2002","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib112","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/jm030947m","article-title":"Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin","volume":"47","author":"Grellepois","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib113","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/jm901216v","article-title":"Modular synthesis and in\u00a0vitro and in\u00a0vivo antimalarial assessment of C-10 pyrrole mannich base derivatives of artemisinin","volume":"53","author":"Pacorel","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib114","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/jm201214d","article-title":"Malaria-infected mice are completely cured by one 6 mg\/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine","volume":"55","author":"Slack","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib115","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1021\/jm00171a041","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3. Aromatic amine analogs","volume":"33","author":"Lin","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib116","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/0960-894X(95)00297-7","article-title":"Artemisinin derivatives with 12-aniline substitution: synthesis and antimalarial activity","volume":"5","author":"Yang","year":"1995","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib117","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/anie.200352343","article-title":"Highly antimalaria-active artemisinin derivatives: biological activity does not correlate with chemical reactivity","volume":"43","author":"Haynes","year":"2004","journal-title":"Angew. Chem., Int"},{"key":"10.1016\/j.ejmech.2021.113193_bib118","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cbic.200400366","article-title":"Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate","volume":"6","author":"Haynes","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2021.113193_bib119","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/anie.200503071","article-title":"Artemisone\u2014a highly active antimalarial drug of the artemisinin class","volume":"45","author":"Haynes","year":"2006","journal-title":"Angew. Chem., Int"},{"key":"10.1016\/j.ejmech.2021.113193_bib120","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1128\/AAC.01585-07","article-title":"First assessment in humans of the safety, tolerability, pharmacokinetics, and ex\u00a0vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone","volume":"52","author":"Nagelschmitz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib121","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in\u00a0vitro and in\u00a0vivo","volume":"59","author":"Vivas","year":"2007","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib122","series-title":"In: Research Advances in Antimicrobial Agents and Chemotherapy","article-title":"Identification of non-neurotoxic artemisinin derivatives in\u00a0vivo and in\u00a0vitro","author":"Schmuck","year":"2003"},{"key":"10.1016\/j.ejmech.2021.113193_bib123","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone effective against murine cerebral malaria","volume":"9","author":"Waknine-Grinberg","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib124","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02214-17","article-title":"Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in Plasmodium falciparum transmissible gametocyte stages","volume":"62","author":"Coertzen","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib125","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.tet.2018.04.027","article-title":"Evaluation and optimization of synthetic routes from dihydroartemisinin to the alkylamino-artemisinins artemiside and artemisone: a test of N-glycosylation methodologies on a lipophilic peroxide","volume":"74","author":"Chan","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.05006-11","article-title":"Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria","volume":"56","author":"Guo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib127","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/AAC.01553-13","article-title":"Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses","volume":"58","author":"Guiguemde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib128","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3389\/fchem.2019.00901","article-title":"Optimal 10-Aminoartemisinins with potent transmission-blocking capabilities for new artemisinin combination therapies\u2013activities against blood stage P. Falciparum including PfKI3 C580Y mutants and liver stage P. Berghei parasites","volume":"7","author":"Wong","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/molecules23071713","article-title":"Facile preparation of N-glycosylated 10-piperazinyl artemisinin derivatives and evaluation of their antimalarial and cytotoxic activities","volume":"23","author":"Wu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113193_bib130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/1995-7645.259240","article-title":"Antimalarial activity of a novel series of artemisinin-derived 1, 2, 3-triazole dimers","volume":"12","author":"Gogoi","year":"2019","journal-title":"Asian Pac. J. Trop. Med"},{"key":"10.1016\/j.ejmech.2021.113193_bib131","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3347\/kjp.2017.55.6.661","article-title":"Antimalarial activity of C-10 substituted triazolyl artemisinin","volume":"55","author":"Park","year":"2017","journal-title":"Kor. J. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113193_bib132","first-page":"3607","article-title":"The case for development of 11-Aza-artemisinins for malaria, Curr","volume":"22","author":"Harmse","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib133","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1021\/jm00026a011","article-title":"Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-Alkyl-11-aza-9-desmethylartemisinins","volume":"38","author":"Avery","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib134","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/jm00026a012","article-title":"Syntheses and antimalarial activities of N-substituted 11-azaartemisinins","volume":"38","author":"Torok","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0040-4039(94)02419-C","article-title":"Synthesis and reactions of 11-azaartemisinin and derivatives","volume":"36","author":"Torok","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib136","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0968-0896(00)00049-3","article-title":"Synthesis and antimalarial activities of base-catalyzed adducts of 11-azaartemisinin","volume":"8","author":"Mekonnen","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib137","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/S0960-894X(99)00506-5","article-title":"Structure and antimalarial activity of adducts of 11-azaartemisinin with conjugated terminal acetylenes","volume":"9","author":"Katz","year":"1999","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib138","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cmdc.200700065","article-title":"Preparation of N-sulfonyl- and N-Carbonyl-11-Azaartemisinins with greatly enhanced thermal stabilities: in\u00a0vitro antimalarial activities","volume":"2","author":"Haynes","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113193_bib139","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cmdc.201700599","article-title":"Activities of 11-azaartemisinin and N-sulfonyl derivatives against asexual and transmissible malaria parasites","volume":"12","author":"Harmse","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113193_bib140","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/jm401774f","article-title":"New orally active amino-and hydroxy-functionalized 11-azaartemisinins and their derivatives with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss Mice 1","volume":"57","author":"Singh","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib141","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1021\/ol802238d","article-title":"Amino-and hydroxy-functionalized 11-azaartemisinins and their derivatives","volume":"10","author":"Singh","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib142","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1016\/j.tetlet.2014.07.027","article-title":"Synthesis of 11-aza-artemisinin derivatives using the Ugi reaction and an evaluation of their antimalarial activity","volume":"55","author":"Le","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib143","first-page":"251","article-title":"Fatal neurotoxicity of arteether and artemether, Am","volume":"51","author":"Brewer","year":"1994","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib144","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1016\/S0040-4039(97)01428-7","article-title":"Copper(I) catalyzed conjugate addition of grignard reagents to Acrylic acids: Homologation of artemisinic acid and subsequent conversion to 9-substituted artemisinin analogs","volume":"38","author":"Vroman","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib145","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1021\/jm020142z","article-title":"Structure\u2212 activity relationships of the antimalarial agent artemisinin. 7. Direct modification of (+)-artemisinin and in\u00a0vivo antimalarial screening of new, potential preclinical antimalarial candidates","volume":"45","author":"Avery","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib146","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1021\/ja407388y","article-title":"Catalyst-controlled Aliphatic C\u2013H oxidations with a predictive model for site-selectivity","volume":"135","author":"Gormisky","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113193_bib147","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1021\/acs.orglett.5b03001","article-title":"Transition-metal-free oxidative Aliphatic C\u2013H Azidation","volume":"17","author":"Zhang","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib148","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1021\/acs.orglett.8b01987","article-title":"Design and de novo synthesis of 6-Aza-artemisinins","volume":"20","author":"Bonepally","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib149","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1021\/acs.joc.0c01017","article-title":"Rapid and systematic exploration of chemical space relevant to artemisinins: anti-malarial activities of skeletally diversified tetracyclic peroxides and 6-Aza-artemisinins","volume":"85","author":"Bonepally","year":"2020","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib150","doi-asserted-by":"crossref","first-page":"127514","DOI":"10.1016\/j.bmcl.2020.127514","article-title":"Structural hybridization as a facile approach to new drug candidates","volume":"30","author":"Sampath Kumar","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib151","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Viktoriya","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib152","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/17460440902956636","article-title":"Drug hybridization strategies: before or after lead identification?","volume":"4","author":"Fraga","year":"2009","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113193_bib153","first-page":"112994","article-title":"Metronidazole-conjugates: a comprehensive review of recent developments towards synthesis and medicinal perspective","author":"Patel","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib154","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejmech.2018.12.035","article-title":"Small molecule-drug conjugates: a novel strategy for cancer-targeted treatment,","volume":"163","author":"Zhuang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/molecules25010066","article-title":"Cinnamic acid conjugates in the rescuing and repurposing of classical antimalarial drugs","volume":"25","author":"Silva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113193_bib156","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejmech.2019.02.003","article-title":"Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt\/mTOR in breast cancer cells","volume":"167","author":"Patel","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib157","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2174\/092986711795328355","article-title":"Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond","volume":"18","author":"Decker","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib158","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/C4MD00091A","article-title":"Synthesis and evaluation of artesunate\u2013indoloquinoline hybrids as antimalarial drug candidates","volume":"5","author":"Wang","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113193_bib159","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acsomega.7b00310","article-title":"Synthesis of novel hybrids of quinazoline and artemisinin with high activities against Plasmodium falciparum, human cytomegalovirus, and leukemia cells","volume":"2","author":"Fr\u00f6hlich","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2021.113193_bib160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/acsmedchemlett.7b00412","article-title":"Synthesis of thymoquinone\u2013artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents","volume":"9","author":"Fr\u00f6hlich","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib161","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsmedchemlett.8b00381","article-title":"Synthesis of artemisinin\u2013estrogen hybrids highly active against HCMV, P. Falciparum, and cervical and breast cancer","volume":"9","author":"Fr\u00f6hlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib162","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acsmedchemlett.9b00669","article-title":"Synthesis of novel G factor or chloroquine-artemisinin hybrids and conjugates with potent antiplasmodial activity","volume":"11","author":"Pepe","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib163","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1016\/j.bmc.2018.05.041","article-title":"Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo) egonol, thymoquinone and artemisinin","volume":"26","author":"Karag\u00f6z","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib164","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib165","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bmcl.2011.01.103","article-title":"Synthesis, in\u00a0vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids","volume":"21","author":"Lombard","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib166","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1475-2875-12-71","article-title":"Potent in\u00a0vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids","volume":"12","author":"Lombard","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib167","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2014.01.014","article-title":"Synthesis and in\u00a0vitro biological evaluation of aminoacridines and artemisinin\u2013acridine hybrids","volume":"56","author":"Joubert","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113193_bib168","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2014.11.016","article-title":"Synthesis and in\u00a0vitro biological evaluation of dihydroartemisinyl-chalcone esters","volume":"90","author":"Smit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib169","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-328X(86)80097-3","article-title":"Metallocenes in biochemistry, microbiology & medicine","volume":"302","author":"Dombrowski","year":"1986","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib170","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/molecules24193604","article-title":"Ferrocene-based compounds with antimalaria\/anticancer activity","volume":"24","author":"Peter","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113193_bib171","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cmdc.200700127","article-title":"Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial","volume":"3","author":"Dive","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113193_bib172","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/aoc.1202","article-title":"On the medicinal chemistry of ferrocene","volume":"21","author":"Fouda","year":"2007","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib173","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1021\/cr0101510","article-title":"Bioorganometallic chemistry of ferrocene","volume":"104","author":"van Staveren","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113193_bib174","first-page":"1409","article-title":"Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study, Lancet Infect","volume":"15","author":"Held","year":"2015","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib175","first-page":"1365","article-title":"Ferroquine: welcome to the next generation of antimalarials, Lancet Infect","volume":"15","author":"Wells","year":"2015","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib176","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"Synthesis and antimalarial activity in\u00a0vitro and in\u00a0vivo of a new ferrocene\u2212 chloroquine analogue","volume":"40","author":"Biot","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib177","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/48.2.179","article-title":"Ferrocene-chloroquine analogues as antimalarial agents: in\u00a0vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum","volume":"48","author":"Pradines","year":"2001","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib178","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s004360000317","article-title":"In\u00a0vitro and in\u00a0vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites","volume":"87","author":"Delhaes","year":"2001","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2021.113193_bib179","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1475-2875-6-81","article-title":"In\u00a0vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border","volume":"6","author":"Barends","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib180","doi-asserted-by":"crossref","first-page":"111791","DOI":"10.1016\/j.ejmech.2019.111791","article-title":"Current scenario of ferrocene-containing hybrids for antimalarial activity","volume":"185","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib181","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1021\/cr3001252","article-title":"Metalloantimalarials","volume":"113","author":"Salas","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113193_bib182","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0968-0896(00)00206-6","article-title":"Novel ferrocenic artemisinin derivatives: synthesis, in\u00a0vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX","volume":"8","author":"Delhaes","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib183","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bmcl.2017.12.057","article-title":"Synthesis, in\u00a0vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives","volume":"28","author":"de Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib184","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.bmcl.2018.08.037","article-title":"Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids","volume":"28","author":"de Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib186","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bmc.2018.11.018","article-title":"Synthesis of new betulinic acid\/betulin-derived dimers and hybrids with potent antimalarial and antiviral activities","volume":"27","author":"Karag\u00f6z","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib187","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","article-title":"A\u00a0novel artemisinin\u2013quinine hybrid with potent antimalarial activity, Bioorg","volume":"17","author":"Walsh","year":"2007","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib188","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.bmcl.2009.02.028","article-title":"Antitumour and antimalarial activity of artemisinin\u2013acridine hybrids","volume":"19","author":"Jones","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib189","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmcl.2009.04.100","article-title":"Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition","volume":"19","author":"Capela","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bcp.2011.04.018","article-title":"Effects of highly active novel artemisinin\u2013chloroquinoline hybrid compounds on \u03b2-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum","volume":"82","author":"Feng","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113193_bib191","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cmdc.201700579","article-title":"Preliminary evaluation of artemisinin\u2013cholesterol conjugates as potential drugs for the treatment of intractable forms of malaria and Tuberculosis","volume":"13","author":"Morake","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113193_bib192","doi-asserted-by":"crossref","first-page":"52","DOI":"10.13171\/mjc91190822625ua","article-title":"Synthesis, characterization and biological evaluation of benzimidazole-dihydroartemisinin hybrids as potential dual acting antimalarial agents","volume":"9","author":"Ajima","year":"2019","journal-title":"Mediterr. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib193","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: potent antimalarial and anticancer agents","volume":"59","author":"Fr\u00f6hlich","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib194","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jhet.3815","article-title":"Artemisinin-derived dimers and their antimalarial activities","volume":"57","author":"Yang","year":"2020","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib195","first-page":"1","article-title":"The chemistry and synthesis of qinghaosu derivatives","volume":"2","author":"Group","year":"1982","journal-title":"J.\u00a0Tradit. Chin. Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib196","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113193_bib197","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1021\/jm001061a","article-title":"Efficient preparations of the \u03b2-glucuronides of dihydroartemisinin and structural confirmation of the human glucuronide metabolite","volume":"44","author":"O\u2019Neill","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib198","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/np9605495","article-title":"Stereochemistry-dependent cytotoxicity of some artemisinin derivatives","volume":"60","author":"Beekman","year":"1997","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113193_bib199","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1021\/ol052056+","article-title":"Synthesis of new artemisinin-derived dimers by self-cross-metathesis reaction","volume":"7","author":"Grellepois","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/156802606776743129","article-title":"From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements","volume":"6","author":"Haynes","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib201","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/jm00011a012","article-title":"Antimalarial activity of novel ring-contracted artemisinin derivatives","volume":"38","author":"Venugopalan","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib202","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0968-0896(97)00079-5","article-title":"Trioxane dimers have potent antimalarial, antiproliferative and antitumor activities in\u00a0vitro","volume":"5","author":"Posner","year":"1997","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib203","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1021\/jm990363d","article-title":"Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers","volume":"42","author":"Posner","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib204","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/jm0303711","article-title":"Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents","volume":"47","author":"Posner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib205","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/jm030974c","article-title":"Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10\u03b2-(2-hydroxyethyl) deoxoartemisinin","volume":"47","author":"Jeyadevan","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib206","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1016\/j.bmc.2009.10.019","article-title":"Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers","volume":"17","author":"Slade","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib207","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/jm058288w","article-title":"Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity","volume":"49","author":"Paik","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib208","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.bmcl.2010.09.123","article-title":"A\u00a0single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice, Bioorg","volume":"21","author":"Moon","year":"2011","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib209","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/jm400058j","article-title":"Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs","volume":"56","author":"Mott","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib210","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.bmcl.2014.04.025","article-title":"Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates","volume":"24","author":"Mazzone","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/wjtcm.wjtcm_10_17","article-title":"New orally active artemisinin dimer antimalarials","volume":"3","author":"ElSohly","year":"2017","journal-title":"World J. Tradit. Chin. Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib212","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.bmcl.2010.09.130","article-title":"Artemisinin\u2013quinoline hybrid-dimers: synthesis and in\u00a0vitro antiplasmodial activity","volume":"20","author":"Lombard","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib213","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejps.2012.09.019","article-title":"Antimalarial and anticancer activities of artemisinin\u2013quinoline hybrid-dimers and pharmacokinetic properties in mice","volume":"47","author":"Lombard","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2021.113193_bib214","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejmech.2014.01.040","article-title":"Synthesis, in\u00a0vitro antiplasmodial activity and cytotoxicity of a series of artemisinin\u2013triazine hybrids and hybrid-dimers","volume":"76","author":"Cloete","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib215","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"Reiter","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib216","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","article-title":"Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action","volume":"24","author":"Fr\u00f6hlich","year":"2018","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2021.113193_bib217","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.3390\/molecules25204858","article-title":"Synthesis and antiplasmodial activity of novel fosmidomycin derivatives and conjugates with artemisinin and Aminochloroquinoline","volume":"25","author":"Palla","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113193_bib218","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(02)11860-5","article-title":"Fosmidomycin for malaria","volume":"360","author":"Missinou","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113193_bib219","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1021\/jm0103007","article-title":"C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene","volume":"44","author":"Ekthawatchai","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib220","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib221","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.2174\/092986711803414340","article-title":"Medicinal chemistry perspectives of trioxanes and tetraoxanes","volume":"18","author":"Kumar","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib222","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/jm020584a","article-title":"A\u00a0short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic \u03b2-sulfonyl-endoperoxides","volume":"46","author":"Bachi","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib223","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1002\/anie.200453859","article-title":"Design and synthesis of endoperoxide antimalarial prodrug models","volume":"43","author":"O\u2019Neill","year":"2004","journal-title":"Angew. Chem., Int"},{"key":"10.1016\/j.ejmech.2021.113193_bib224","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1021\/jo050074z","article-title":"Total syntheses of yingzhaosu A and of its C (14)-epimer including the first evaluation of their antimalarial and cytotoxic activities","volume":"70","author":"Szpilman","year":"2005","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib225","first-page":"261","article-title":"Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity","volume":"45","author":"Hofheinz","year":"1994","journal-title":"Trop. Med. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113193_bib226","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1021\/jm980088f","article-title":"Antimalarial cyclic peroxy ketals","volume":"41","author":"Posner","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib227","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.tetlet.2012.12.075","article-title":"A\u00a0synthetic strategy to bridged 2, 3, 8-trioxabicyclo [3, 3, 1] nonane endoperoxides","volume":"54","author":"Gemma","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib228","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/j.tet.2009.07.030","article-title":"\u03b1-Spiro endoperoxides: synthesis and evaluation of their antimalarial activities","volume":"65","author":"Bernat","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib229","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1021\/ja502208z","article-title":"Four-step synthesis of the antimalarial cardamom peroxide via an oxygen stitching strategy","volume":"136","author":"Hu","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113193_bib230","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1016\/j.tet.2018.03.045","article-title":"Synthesis and study of the antimalarial cardamom peroxide","volume":"74","author":"Hu","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib231","doi-asserted-by":"crossref","first-page":"103020","DOI":"10.1016\/j.bioorg.2019.103020","article-title":"Bridged bicyclic 2, 3-dioxabicyclo [3.3. 1] nonanes as antiplasmodial agents: synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe (II)","volume":"89","author":"D\u2019Alessandro","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib232","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jm00399a004","article-title":"1, 2, 4-Trioxanes as potential antimalarial agents","volume":"31","author":"Kepler","year":"1988","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib233","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1021\/jm00091a014","article-title":"Extraordinarily potent antimalarial compounds: new, structurally simple, easily synthesized, tricyclic 1, 2, 4-trioxanes","volume":"35","author":"Posner","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib234","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0960-894X(00)80177-8","article-title":"Synthesis of in\u00a0vivo potent antimalarial 1, 2, 4-trioxanes","volume":"2","author":"Singh","year":"1992","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib235","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hlca.19950780312","article-title":"Synthesis, structure, and antimalarial activity of some enantiomerically pure, cis-fused cyclopenteno-1, 2, 4-trioxanes","volume":"78","author":"Jefford","year":"1995","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2021.113193_bib236","doi-asserted-by":"crossref","first-page":"240","DOI":"10.22270\/jddt.v10i4-s.4268","article-title":"A\u00a0review on antimalarial 1, 2, 4-trioxane derivatives","volume":"10","author":"Choudhary","year":"2020","journal-title":"J.\u00a0Drug Deliv. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113193_bib237","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bmcl.2003.10.051","article-title":"Orally active amino functionalized antimalarial 1, 2, 4-trioxanes","volume":"14","author":"Singh","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib238","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bmc.2003.11.021","article-title":"Synthesis and antimalarial activity of a new series of trioxaquines","volume":"12","author":"Singh","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib239","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1016\/j.bmcl.2005.07.013","article-title":"New orally active spiro 1, 2, 4-trioxanes with high antimalarial potency","volume":"15","author":"Singh","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib240","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1021\/jm051130r","article-title":"Orally active 1, 2, 4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-Arylvinyl)-1, 2, 5-trioxaspiro [5.5] undecanes against multi-drug-resistant Plasmodium yoelii nigeriensis in mice","volume":"49","author":"Singh","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib241","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1016\/j.bmc.2004.08.042","article-title":"Synthesis and antimalarial activity of 6-cycloalkylvinyl substituted 1, 2, 4-trioxanes","volume":"12","author":"Singh","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib242","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/jm0610043","article-title":"New adamantane-based spiro 1, 2, 4-trioxanes orally effective against rodent and simian malaria","volume":"50","author":"Singh","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib243","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1021\/jm100678p","article-title":"Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1, 2, 4-trioxanes","volume":"53","author":"Singh","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib244","series-title":"Substituted 1, 2, 4-trioxanes as Antimalarial Agents and a Process of Producing the Substituted 1, 2, 4-trioxanes","author":"Singh","year":"2001"},{"key":"10.1016\/j.ejmech.2021.113193_bib245","article-title":"Single ascending dose safety and pharmacokinetics of CDRI-97\/78: first-in-human study of a novel antimalarial drug","volume":"2014","author":"Shafiq","year":"2014","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ejmech.2021.113193_bib246","article-title":"Time course of the changes in novel trioxane antimalarial 99\/411 pharmacokinetics upon antiepileptic drugs co-administration in SD rats","volume":"2014","author":"Singh","year":"2014","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ejmech.2021.113193_bib247","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/bmc.1635","article-title":"Determination of metabolic profile of anti-malarial trioxane CDRI 99\/411 in rat liver microsomes using HPLC","volume":"26","author":"Mishra","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejmech.2021.113193_bib248","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/bmc.3782","article-title":"Pharmacokinetic studies of a novel trioxane antimalarial (99\/411) in rats and monkeys using LC\u2013MS\/MS","volume":"30","author":"Pandey","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejmech.2021.113193_bib249","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1021\/jm301323k","article-title":"Bile acid-based 1,2,4-trioxanes: synthesis and antimalarial assessment","volume":"55","author":"Singh","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bmcl.2004.11.043","article-title":"Novel spiroanellated 1, 2, 4-trioxanes with high in\u00a0vitro antimalarial activities","volume":"15","author":"Griesbeck","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib251","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/ml300188t","article-title":"Synthesis and antimalarial activity of 3, 3-spiroanellated 5, 6-disubstituted 1, 2, 4-trioxanes","volume":"4","author":"Maurya","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib252","doi-asserted-by":"crossref","first-page":"1600335","DOI":"10.1002\/ardp.201600335","article-title":"Design, synthesis, and biological evaluation of novel 1,2,4-trioxanes as potential antimalarial agents","volume":"350","author":"Gupta","year":"2017","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2021.113193_bib253","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1021\/jm801006v","article-title":"Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice","volume":"51","author":"Singh","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib254","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jm100117e","article-title":"Trioxaferroquines as new hybrid antimalarial drugs","volume":"53","author":"Bellot","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib255","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.bmcl.2012.04.100","article-title":"Coumarin\u2013trioxane hybrids: synthesis and evaluation as a new class of antimalarial scaffolds","volume":"22","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib256","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/14756366.2017.1363742","article-title":"Novel series of 1, 2, 4-trioxane derivatives as antimalarial agents","volume":"32","author":"Rudrapal","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib257","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00044-017-2090-8","article-title":"Newer series of trioxane derivatives as potent antimalarial agents","volume":"27","author":"Rudrapal","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113193_bib258","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/cmdc.202000045","article-title":"Design, synthesis, structure-activity relationship and docking studies of novel functionalized arylvinyl-1,2,4-trioxanes as potent antiplasmodial as well as anticancer agents","volume":"15","author":"Tiwari","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113193_bib259","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/1568026619666190412104042","article-title":"Recent developments in natural product inspired synthetic 1, 2, 4-trioxolanes (ozonides): an unusual entry into antimalarial chemotherapy","volume":"19","author":"Tiwari","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pt.2019.05.002","article-title":"Ozonide antimalarial activity in the context of artemisinin-resistant malaria","volume":"35","author":"Giannangelo","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113193_bib261","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113193_bib262","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1248\/cpb.26.331","article-title":"Structure of gilvanol, a new triterpene isolated from Quercus gilva Blume","volume":"26","author":"Itokawa","year":"1978","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2021.113193_bib263","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0040-4039(01)91430-3","article-title":"Fern constituent: naturally occurring adian-5-ene ozonide in the leaves of Adiantum monochlamys and Oleandra wallichii","volume":"19","author":"Ageta","year":"1978","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib264","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1039\/p19920003251","article-title":"Synthesis of some stable ozonides with anti-malarial activity","volume":"1","author":"De Almeida Barbosa","year":"1992","journal-title":"J.\u00a0Chem. Soc., Perkin Trans."},{"key":"10.1016\/j.ejmech.2021.113193_bib265","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1039\/p19960001101","article-title":"The design, synthesis and biological evaluation of stable ozonides with antimalarial activity","volume":"1","author":"Barbosa","year":"1996","journal-title":"J.\u00a0Chem. Soc., Perkin Trans."},{"key":"10.1016\/j.ejmech.2021.113193_bib266","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02779","article-title":"Identification of an antimalarial synthetic trioxolane drug development candidate","volume":"430","author":"Vennerstrom","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113193_bib267","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1021\/jm049040u","article-title":"Spiro and dispiro-1,2,4-trioxolanes as antimalarial Peroxides: charting a workable Structure\u2212Activity relationship using simple prototypes","volume":"48","author":"Dong","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib268","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1016\/j.bmcl.2006.08.046","article-title":"Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1, 2, 4-trioxolane piperidine","volume":"16","author":"Padmanilayam","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib269","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bmcl.2006.12.007","article-title":"Weak base dispiro-1, 2, 4-trioxolanes: potent antimalarial ozonides","volume":"17","author":"Tang","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/jm901473s","article-title":"The structure\u2212 activity relationship of the antimalarial ozonide Arterolane (OZ277)","volume":"53","author":"Dong","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib271","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bmcl.2009.11.088","article-title":"The comparative antimalarial properties of weak base and neutral synthetic ozonides, Bioorg","volume":"20","author":"Tang","year":"2010","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib272","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bmcl.2008.01.087","article-title":"Characterization of the two major CYP450 metabolites of ozonide (1, 2, 4-trioxolane) OZ277","volume":"18","author":"Zhou","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113193_bib273","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria, Proc. Natl. Acad","volume":"108","author":"Charman","year":"2011","journal-title":"Sci. U. S. A., Early"},{"key":"10.1016\/j.ejmech.2021.113193_bib274","first-page":"684","article-title":"Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial, clin. Infect","volume":"51","author":"Valecha","year":"2010","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib275","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1021\/acs.jmedchem.7b00299","article-title":"Seeking the elusive long-acting ozonide: discovery of artefenomel (OZ439)","volume":"60","author":"Kim","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib276","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1021\/acs.jmedchem.6b01586","article-title":"Structure\u2013activity relationship of the antimalarial ozonide artefenomel (OZ439)","volume":"60","author":"Dong","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib277","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12936-017-1696-0","article-title":"In\u00a0vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate","volume":"16","author":"Baumg\u00e4rtner","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib278","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12936-019-3056-8","article-title":"Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay","volume":"18","author":"Walz","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib279","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01566-17","article-title":"Parasite-mediated degradation of synthetic ozonide antimalarials impacts in\u00a0vitro antimalarial activity","volume":"62","author":"Giannangelo","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12916-017-0940-3","article-title":"A\u00a0randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria,","volume":"15","author":"Macintyre","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2021.113193_bib281","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/acsinfecdis.0c00064","article-title":"Antimalarial trioxolanes with superior drug-like properties and in\u00a0vivo efficacy","volume":"6","author":"Blank","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib282","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2017.09.040","article-title":"Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolane-polyamine conjugates","volume":"140","author":"Pearce","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib283","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.steroids.2017.11.008","article-title":"Synthesis and antimalarial activity of 3\u2032-trifluoromethylated 1,2,4-trioxolanes and 1,2,4,5-tetraoxane based on deoxycholic acid","volume":"129","author":"Yamansarov","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2021.113193_bib284","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12936-018-2281-x","article-title":"New endoperoxides highly active in\u00a0vivo and in\u00a0vitro against artemisinin-resistant Plasmodium falciparum","volume":"17","author":"Lobo","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib285","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1389557514666140123144942","article-title":"Tetraoxanes as antimalarials: harnessing the endoperoxide","volume":"14","author":"Fisher","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib286","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1389557024605537","article-title":"Synthesis and antimalarial activity of 1, 2, 4, 5-tetraoxanes","volume":"2","author":"Dong","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib287","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/med.10066","article-title":"Synthetic peroxides as antimalarials","volume":"24","author":"Tang","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113193_bib288","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2298\/JSC0911155O","article-title":"Antimalarial peroxides","volume":"74","author":"Opsenica","year":"2009","journal-title":"J.\u00a0Serb. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113193_bib289","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1021\/jm0000766","article-title":"Synthesis and antimalarial activity of sixteen dispiro-1, 2, 4, 5-tetraoxanes: alkyl-substituted 7, 8, 15, 16-Tetraoxadispiro [5.2. 5.2] hexadecanes","volume":"43","author":"Vennerstrom","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib290","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/jm00094a015","article-title":"Dispiro-1, 2, 4, 5-tetraoxanes: a new class of antimalarial peroxides","volume":"35","author":"Vennerstrom","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib291","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/jm990530+","article-title":"Methyl-substituted dispiro-1, 2, 4, 5-tetraoxanes: correlations of structural studies with antimalarial activity","volume":"43","author":"McCullough","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib292","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0039-128X(96)00203-6","article-title":"Steroidal geminal dihydroperoxides and 1, 2, 4, 5-tetraoxanes: structure determination and their antimalarial activity","volume":"61","author":"Todorovi\u0107","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2021.113193_bib293","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1021\/jm000952f","article-title":"Cholic acid derivatives as 1, 2, 4, 5-tetraoxane carriers: structure and antimalarial and antiproliferative activity","volume":"43","author":"Opsenica","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib294","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/acs.jmedchem.5b01374","article-title":"Reinvestigating old pharmacophores: are 4-aminoquinolines and tetraoxanes potential two-stage antimalarials?","volume":"59","author":"Terzi\u0107","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib295","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/jac\/dkt165","article-title":"A\u00a0Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection","volume":"68","author":"D\u2019Alessandro","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib296","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1039\/b613565j","article-title":"Design and synthesis of orally active dispiro 1, 2, 4, 5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin","volume":"4","author":"Amewu","year":"2006","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib297","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1021\/jm701435h","article-title":"Two-step synthesis of achiral dispiro-1, 2, 4, 5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles","volume":"51","author":"Ellis","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib298","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1002\/anie.201001026","article-title":"Identification of a 1, 2, 4, 5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins","volume":"49","author":"O\u2019Neill","year":"2010","journal-title":"Angew. Chem., Int"},{"key":"10.1016\/j.ejmech.2021.113193_bib299","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1039\/c1md00102g","article-title":"Second generation analogues of RKA182: synthetic tetraoxanes with outstanding in\u00a0vitro and in\u00a0vivo antimalarial activities","volume":"2","author":"Marti","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113193_bib300","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cmdc.201100196","article-title":"Antimalarial mannoxanes: hybrid antimalarial drugs with outstanding oral activity profiles and A potential dual mechanism of action","volume":"6","author":"Chadwick","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113193_bib301","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1016\/j.bmcl.2010.09.113","article-title":"The structure and antimalarial activity of dispiro-1, 2, 4, 5-tetraoxanes derived from (+)-dihydrocarvone, Bioorg","volume":"20","author":"Dong","year":"2010","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib302","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/jm980698f","article-title":"Synthesis and antimalarial activity of 11 dispiro-1, 2, 4, 5-tetraoxane analogues of WR 148999. 7, 8, 15, 16-Tetraoxadispiro [5.2. 5.2] hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups","volume":"42","author":"Dong","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib303","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1016\/j.bmc.2009.06.020","article-title":"Synthesis, antimalarial activity and cytotoxicity of substituted 3, 6-diphenyl-[1, 2, 4, 5] tetraoxanes","volume":"17","author":"Kumar","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib304","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.ejmech.2011.04.002","article-title":"Synthesis and in\u00a0vitro antimalarial activity of tetraoxane-amine\/amide conjugates","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib305","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1016\/j.bmc.2013.09.047","article-title":"Synthesis and evaluation of the antimalarial, anticancer, and caspase 3 activities of tetraoxane dimers","volume":"21","author":"Amewu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib306","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1016\/j.tet.2016.08.043","article-title":"Optimisation of the synthesis of second generation 1, 2, 4, 5 tetraoxane antimalarials","volume":"72","author":"O\u2019Neill","year":"2016","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113193_bib307","first-page":"1","article-title":"A\u00a0tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance, Nat","volume":"8","author":"O\u2019Neill","year":"2017","journal-title":"Commun. Now."},{"key":"10.1016\/j.ejmech.2021.113193_bib308","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.bmc.2018.05.006","article-title":"Synthesis and profiling of benzylmorpholine 1, 2, 4, 5-tetraoxane analogue N205: towards tetraoxane scaffolds with potential for single dose cure of malaria","volume":"26","author":"O\u2019Neill","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib309","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1021\/jm8006905","article-title":"New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton","volume":"51","author":"Opsenica","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/ml4002985","article-title":"Novel endoperoxide-based transmission-blocking antimalarials with liver-and blood-schizontocidal activities","volume":"5","author":"Miranda","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113193_bib311","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2018.02.048","article-title":"Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability","volume":"149","author":"Capela","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib312","first-page":"1","article-title":"In silico modeling of tetraoxane-8-aminoquinoline hybrids active against Plasmodium falciparum","volume":"9","author":"Mahmud","year":"2020","journal-title":"Beni-Suef Univ. J. Appl. Sci."},{"key":"10.1016\/j.ejmech.2021.113193_bib313","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/jm5004528","article-title":"Tetraoxane\u2013pyrimidine nitrile hybrids as dual stage antimalarials","volume":"57","author":"Oliveira","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib314","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5530\/ijper.50.4.11","article-title":"Synthesis and antimalarial activity evaluation of some mannich bases of tetraoxane-phenol conjugate","volume":"50","author":"Jinky","year":"2016","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.ejmech.2021.113193_bib315","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11094-019-02085-x","article-title":"Design and discovery of 3, 6-substituted 1, 2, 4, 5-tetraoxanes as new class of falcipain-2 inhibitors for antimalarial action","volume":"53","author":"Kumawat","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2021.113193_bib316","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/jm00398a026","article-title":"Arteether, a new antimalarial drug: synthesis and antimalarial properties","volume":"31","author":"Brossi","year":"1988","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib317","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5694\/j.1326-5377.2005.tb06650.x","article-title":"Artemisinin-based combination therapies for uncomplicated malaria","volume":"182","author":"Davis","year":"2005","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejmech.2021.113193_bib318","first-page":"716","article-title":"Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia\u2013Thailand border, Emerging Infect","volume":"14","author":"Wongsrichanalai","year":"2008","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib319","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/AAC.00835-15","article-title":"Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment","volume":"59","author":"Leang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113193_bib320","first-page":"952","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study, Lancet Infect","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib321","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai\u2013Myanmar border (2003\u20132013): the role of parasite genetic factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib322","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib323","first-page":"715","article-title":"Treatment failure of dihydroartemisinin\/piperaquine for Plasmodium falciparum malaria, Vietnam, Emerging Infect","volume":"23","author":"Phuc","year":"2017","journal-title":"Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib324","article-title":"Clinical and in\u00a0vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia","author":"Mairet-Khedim","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113193_bib325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/molecules22010117","article-title":"Synthetic strategies for peroxide ring construction in artemisinin","volume":"22","author":"Vil","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113193_bib326","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fpls.2018.00087","article-title":"Approaches and recent developments for the commercial production of semi-synthetic artemisinin","volume":"9","author":"Kung","year":"2018","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ejmech.2021.113193_bib327","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/156802612799362940","article-title":"Synthetic peroxides as potent antimalarials. News and views","volume":"12","author":"Jefford","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113193_bib328","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/13543776.2012.724063","article-title":"Artemisinin derivatives: a patent review (2006\u2013present)","volume":"22","author":"Njuguna","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113193_bib329","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1021\/jm400004u","article-title":"Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-Dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres","volume":"56","author":"Wang","year":"2013","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:23:56Z","timestamp":1759328636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":329,"alternative-id":["S0223523421000428"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113193","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113193"}}